CPAP呼吸机、氨溴索联合用于新生儿呼吸窘迫综合症的效果观察  

CPAP ventilator, ambroxol combined used to observe the effect of neonatal respiratory distress syndrome

作　　者：李学农[1] 杜娇娇[1] 常香云[1] 侯春蕾[1] 王瑞芹[1] 

机构地区：[1]黑龙江省大庆龙南医院齐齐哈尔第五附属医院儿科,163453

出　　处：《家庭心理医生》2015年第6期443-444,共2页Family Therapist

摘　　要：目的：探讨CPAP呼吸机、氨溴索联合用于新生儿呼吸窘迫综合症的临床效果。方法：选取新生儿呼吸窘迫综合症患者88例，将其分为对照组和观察组。对照组患者采用常规的通气治疗法，观察组患者采用CPAP呼吸机、氨溴索联合治疗。结果：两组患者经过治疗生命体征恢复正常，FiO2、PaCO2指标显著降低，PaO2呈升高趋势。观察组患者的治愈率为95．45％，对照组患者的治愈率84．09％，而且在观察指标比较方面，观察组的优势更为明显，住院时间明显短于对照组。结论：CPAP呼吸机、氨溴索联合治疗新生儿呼吸窘迫综合症具有氧疗时间和住院时间短，治愈率高，并发症发生几率小的特点，治疗效果显著，具有极强的医学价值，值得临床推广。Objective： To investigate the CPAP ventilator, ambroxol combined with clinical results for neonatal respiratory distress syndrome. Method： choose 88 cases of neonatal respiratory distress syndrome patients,divided into the observation group and the control group. Patients in the control group using conventionalventilation therapy, the observation group were treated with CPAP ventilator, ambrexol combined therapy. Results： the two groups of patientS after treatment back to normal life signs, FiO2, PaCO2 were significantly decreased,PaO2 increased. PatientS in the observation group. The cure rate was 95.45%, the cure rate of 84.09% patients in the control group, but in comparison to the observation index, advantages of the observation group is more obvious, the duration of hospital stay was significantly shorter than that in control group. Conclusion： CPAP ventilator, ambroxol combined therapy for neonatal respiratory distress syndrome with oxygen therapy time and the hospitalization time is short, the cure rate is high, the probability of oeourrence characteristics of minor complications, treatment effect significantly, has the very strong medical value, is worth the clinical promotion.

关 键 词：CPAP呼吸机 氨溴索 新生儿 呼吸窘迫综合症 

分 类 号：R725.6[医药卫生—儿科]